AstraZeneca has briefed councillors on their plans to build a new office and conference centre at the Cambridge Biomedical ...

AstraZeneca (AZN) announced Enhertu in combination with pertuzumab has been granted Breakthrough Therapy Designation in the U.S. for the first-line treatment of adult patients with unresectable or ...